AllerVie Health Presents New Clinical Research-Focused Brand

DALLAS, TEXAS / AGILITYPR.NEWS / June 01, 2022 / Today, AllerVie Health announced the milestone accomplishment and unveiling of the new brand for their affiliate, AllerVie Clinical Research. Formerly known as Clinical Research Center of Alabama, AllerVie Clinical Research brings cutting-edge treatments and medical advancements to patients who need them most by contributing to the development of innovative, new therapies that connect patients and physicians to the future of medicine.

Championing innovative clinical research built to scale for pharmaceutical sponsorship partners, Contract Research Organizations, and patients across the United States, AllerVie Clinical Research offers more clinical research studies in asthma, allergy, and related immunological conditions than any other organization in the nation through our network of national clinical research sites.

In collaborative partnership with sponsors and AllerVie board-certified allergists, AllerVie Clinical Research is pioneering new therapies based on years of experience in clinical research and the field of allergy and immunology. This rebranding positions AllerVie Clinical Research for increased nationwide expansion, mirroring the dynamic growth of AllerVie Health’s allergy clinic footprint over the last 15 months. Together, the two organizations are poised for continued growth with eyes on the future.

“We firmly believe that best practice is derived from the best clinical research,” said Chief Research Officer, Dr. John Anderson. “As we expand our clinical research footprint in tandem with our allergy clinic footprint, we have complete confidence in our ability to pursue life-changing clinical trials in diverse populations across the country. We believe that hope is having options, and the work that we are doing has life-transforming impact on patients today and into the future.”

National Director of Research, Christopher Ingraham, Ph.D., agrees, “We are unique and transformative in this space in our approach to combining best clinical practice across the country with a network of clinical research sites. We are taking care of the administrative aspects of clinical research so that our allergists and immunologists can still see patients, operate productive and thriving practices, and contribute to the future of medicine through clinical research. In this model, everyone wins.”

Learn more about how AllerVie Clinical Research is changing lives every day for participating patients, our clinical research studies, and our past sponsorship partners by visiting www.allervieclinicalresearch.com.

About AllerVie Health

AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, currently serving patients across 12 states in over 75 clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom! To learn more about our practices, our approach, and our vision, visit www.allervie.com.

About AllerVie Clinical Research

AllerVie Clinical Research, an affiliate of AllerVie Health, conducts clinical studies in adult and pediatric patients, contributing to the advancement of new therapies for asthma, allergies, and other related immunological conditions. We provide access to otherwise unavailable treatments to patients suffering from these conditions. As the fastest growing national network of clinical research sites specializing in allergy and asthma-related studies, AllerVie Clinical Research provides comprehensive care to patients nationwide employing the most efficacious and up-to-date treatments—including biologics. Highly regarded for their standards of excellence, our providers have been conducting clinical trials for pharmaceutical companies and Contract Research Organizations since 1998, giving us more than 20 years of successful clinical research experience in this area of immunological diseases. To learn more, visit www.allervieclinicalresearch.com.

Contact

Rachel Russell

Chief Marketing Officer

[email protected]

Phone: (214) 227-8112

www.allervie.com